Resolution of macular oedema in Coats' disease with intravitreal bevacizumab

Article

A 13-year-old boy was referred because of visual deterioration in his right eye. The visual acuity was two metres of counting fingers. Indirect ophthalmoscopy and biomicroscopy revealed exudative macular oedema as well as tumour-like telangiectatic vessels and exudation in temporal periphery.

A 13-year-old boy was referred because of visual deterioration in his right eye. The visual acuity was two metres of counting fingers. Indirect ophthalmoscopy and biomicroscopy revealed exudative macular oedema as well as tumour-like telangiectatic vessels and exudation in temporal periphery. With diagnosis of Coats' disease (stage II) confirmed by fluorescein angiography, three intravitreal injections of bevacizumab were performed at 6-week intervals. One year after the last injection, there was a significant resolution of macular oedema as well as visual acuity improvement to 20/20. This is the first case report in which a distinct improvement in macular oedema was observed with intravitreal bevacizumab in Coats' disease.

To read the full case click here

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.